MarketCapExport financials
Xtant Medical Holdings (XTNT)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
Xtant Medical Holdings Cash Flow 2025-2009 | XTNT
Brief cash flow overview of Xtant Medical Holdings
The comparison covers five available annual reports between 2021 and 2025.
Operating cash flow advanced from $439 thousand to $12.5 million. A +2,757.9% gain and 131.2% CAGR show rapidly improving cash generation.
Only 2 of five annual observations were positive, indicating weak repeatability.
Cash from operations as a share of revenue increased from 0.8% to 9.4%, improving cash efficiency.
Estimated working capital increased by $21.7 million, equal to 16.2% of latest revenue. More cash became tied up in receivables and inventory.
Overall assessment
Xtant Medical Holdings's cash flow is not clear-cut. Operating receipts exist, but their stability or the residual after investment needs attention.
Annual Cash Flow Xtant Medical Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
12.5 M | -11.9 M | -9.52 M | -5.34 M | 439 K | -731 K | -413 K | 1.21 M | -543 K | -14.4 M | -9.1 M | -7.32 M | -4.89 M | -10.8 M | -7.36 M | -8.37 M | - |
Depreciation & Amortization |
5.22 M | 4.22 M | 3.17 M | 1.29 M | 1.33 M | 2.08 M | 3.14 M | 6.59 M | 8.41 M | 7.24 M | 4.89 M | 952 K | 754 K | 783 K | 755 K | 683 K | - |
Accounts Payables |
3.84 M | 7.92 M | 7.05 M | 3.49 M | 2.62 M | 2.29 M | 2.19 M | 6.46 M | 9.32 M | 10.5 M | 9.39 M | 3.88 M | 2.77 M | 4 M | 2.65 M | 2.26 M | - |
Accounts Receivables |
17.8 M | 20.7 M | 21.7 M | 10.9 M | 7.15 M | 6.88 M | 10.1 M | 9.99 M | 12.7 M | 19 M | 15.4 M | 4.43 M | 4.79 M | 7.15 M | 7.08 M | 3.52 M | - |
Total Inventories |
30.3 M | 38.6 M | 36.9 M | 17.3 M | 17.9 M | 21.4 M | 16.1 M | 17.3 M | 22.2 M | 26.3 M | 22.7 M | 9.56 M | 10.8 M | 13.1 M | 8.48 M | 5.44 M | - |
All numbers in USD currency
Quarterly Cash Flow Xtant Medical Holdings
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | -2.11 M | - | - | - | 1.28 M | - | - | - | -5.76 M | - | - | - | -2.24 M | - | -3.05 M | - | -1 M | - | 16 K | - | -1.31 M | - | -1.65 M | -1.58 M | -1.79 M | - | -342 K | 954 K | 490 K | - | -779 K | 344 K | 236 K | - | -1.19 M | -756 K | 437 K | - | -11.2 M | -7.75 M | 1.03 M | - | - | - | -2.08 M | - | -5.17 M | -3.87 M | -2.19 M | - | - | - | -2.28 M | - | -7.81 M | -4.86 M | -2.94 M | - | -6.42 M | -4.45 M | -1.59 M |
Depreciation & Amortization |
500 K | 534 K | - | 700 K | 800 K | 1.07 M | - | 700 K | 500 K | 1 M | - | 500 K | 400 K | 471 K | - | 400 K | 300 K | 281 K | - | 1.04 M | 300 K | 375 K | - | 1.66 M | 1.15 M | 685 K | - | 2.34 M | 1.56 M | 776 K | - | 4.94 M | 3.23 M | 1.59 M | - | 7.43 M | 4.17 M | 2.07 M | - | 5.55 M | 3.65 M | 1.78 M | - | 2.4 M | 447 K | 235 K | - | 498 K | 346 K | 169 K | - | 587 K | 395 K | 200 K | - | 577 K | 403 K | 214 K | - | 803 K | 322 K | 291 K |
Accounts Payables |
3.84 M | 5.48 M | 7.92 M | 6.86 M | 7.22 M | 7.12 M | 7.92 M | 8.3 M | 6.88 M | 7.38 M | 7.05 M | 5.36 M | 4.44 M | 3.42 M | 3.49 M | 3.78 M | - | 2.77 M | 2.62 M | 2.36 M | 2.64 M | 2.49 M | 2.95 M | 2.95 M | 2.95 M | 2.95 M | 2.19 M | 2.19 M | 2.19 M | 2.19 M | 6.46 M | 6.46 M | 6.46 M | 6.46 M | 9.32 M | 9.32 M | 9.32 M | 9.32 M | 10.5 M | 10.5 M | 10.5 M | 10.5 M | 9.39 M | 9.39 M | 9.39 M | 9.39 M | 3.88 M | 3.88 M | 3.88 M | 3.88 M | 2.77 M | 2.77 M | 2.77 M | 2.77 M | 4 M | 4 M | 4 M | 4 M | 2.65 M | 2.65 M | 2.65 M | 2.65 M |
Accounts Receivables |
17.8 M | 17.2 M | 21.7 M | 25.5 M | 27 M | 23.5 M | 20.7 M | 20.5 M | 21.2 M | 21.5 M | 20.7 M | 19.2 M | 13.7 M | 11.9 M | 10.9 M | 9.84 M | - | 7.54 M | 7.15 M | 6.32 M | 6.98 M | 7.03 M | 6.88 M | 6.88 M | 6.88 M | 6.88 M | 10.1 M | 10.1 M | 10.1 M | 10.1 M | 9.99 M | 9.99 M | 9.99 M | 9.99 M | 12.7 M | 12.7 M | 12.7 M | 12.7 M | 19 M | 19 M | 19 M | 19 M | 15.4 M | 15.4 M | 15.4 M | 15.4 M | 4.43 M | 4.43 M | 4.43 M | 4.43 M | 4.79 M | 4.79 M | 4.79 M | 4.79 M | 7.15 M | 7.15 M | 7.15 M | 7.15 M | 7.08 M | 7.08 M | 7.08 M | 7.08 M |
Total Inventories |
30.3 M | 31.9 M | 38.6 M | 40.7 M | 40.1 M | 38.8 M | 38.6 M | 41.9 M | 40.5 M | 38.7 M | 36.9 M | 34.3 M | 20.4 M | 18.5 M | 17.3 M | 17 M | - | 17.3 M | 17.9 M | 19.7 M | 21.1 M | 21.6 M | 21.4 M | 21.4 M | 21.4 M | 21.4 M | 16.1 M | 16.1 M | 16.1 M | 16.1 M | 17.3 M | 17.3 M | 17.3 M | 17.3 M | 22.4 M | 22.2 M | 22.2 M | 22.2 M | 26.3 M | 26.3 M | 26.3 M | 26.3 M | 22.7 M | 22.7 M | 22.7 M | 22.7 M | 9.56 M | 9.56 M | 9.56 M | 9.56 M | 10.8 M | 10.8 M | 10.8 M | 10.8 M | 13.1 M | 13.1 M | 13.1 M | 13.1 M | 8.48 M | 8.48 M | 8.48 M | 8.48 M |
All numbers in USD currency
Cash Flow Statement is one of the three key financial reports of the company Xtant Medical Holdings, reflecting the actual cash inflows and outflows over a certain period. Unlike the income statement, which shows revenues and expenses on an accrual basis, the cash flow statement focuses on real cash flows — how much cash actually came into the company and how much was spent.
Main Sections of the Cash Flow Statement- Operating Activities
This section reflects cash flows related to the company’s core operations: receipts from sales of goods and services, payments to suppliers, employee salaries, taxes, and other operating expenses. Positive cash flow from operating activities indicates the viability of the business and its ability to generate cash. - Investing Activities
Shows cash movements related to the purchase and sale of long-term assets such as real estate, equipment, and investments in other companies. Negative cash flow here often indicates investments in growth, which can be a positive sign. - Financing Activities
Reflects the inflow and outflow of cash related to raising and repaying capital: issuing shares, loans, dividend payments, and loan repayments. This section shows how the company finances its activities and distributes profits.
The cash flow statement is important for investors because it allows them to assess the company’s real liquidity, showing whether it has enough cash to cover current obligations and investments — this is critical for financial stability. Additionally, it helps analyze the quality of earnings, since profits reported in the income statement can be "paper" profits and may not reflect actual cash inflows; the cash flow statement reveals this difference. The presence of free cash is also crucial for evaluating the company’s ability to finance growth and pay dividends, which is important for investors. Attention should also be paid to prolonged negative cash flows from operating activities, as this may serve as a warning sign of potential problems with the core business.
Cash flow statements of other stocks in the Medical devices sector
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
Conformis
CFMS
|
- | - | $ 16.4 M |  USA |
 |
Boston Scientific Corporation
BSX
|
$ 43.92 | 0.06 % | $ 65 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
$ 8.52 | 0.06 % | $ 621 M |  Israel |
 |
ClearPoint Neuro
CLPT
|
$ 14.83 | 1.51 % | $ 420 M | USA |
 |
CONMED Corporation
CNMD
|
$ 45.38 | 0.44 % | $ 1.41 B | USA |
 |
Cytosorbents Corporation
CTSO
|
$ 4.38 | 1.86 % | $ 273 M | USA |
 |
Delcath Systems
DCTH
|
$ 15.6 | 0.75 % | $ 559 M | USA |
 |
Eargo
EAR
|
- | - | $ 10.2 M | USA |
 |
Medigus Ltd.
MDGS
|
- | 10.28 % | $ 55.5 M | Israel |
 |
Electromed
ELMD
|
$ 27.88 | 0.07 % | $ 230 M | USA |
 |
Cutera
CUTR
|
- | -10.19 % | $ 1.99 M | USA |
 |
Establishment Labs Holdings
ESTA
|
$ 65.97 | 0.59 % | $ 1.95 B |  Costa-rica |
 |
Edwards Lifesciences Corporation
EW
|
$ 86.29 | 0.66 % | $ 50.5 B | USA |
 |
Nemaura Medical
NMRD
|
- | -17.8 % | $ 2.74 M |  Britain |
 |
Helius Medical Technologies
HSDT
|
$ 2.94 | 1.38 % | $ 64.8 M | USA |
 |
AdaptHealth Corp.
AHCO
|
$ 5.64 | 1.26 % | $ 762 M | USA |
 |
Inogen
INGN
|
$ 5.36 | 2.49 % | $ 143 M | USA |
 |
InMode Ltd.
INMD
|
$ 14.26 | 0.49 % | $ 922 M | Israel |
 |
Inspire Medical Systems
INSP
|
$ 70.5 | 2.46 % | $ 2.07 B | USA |
 |
IRIDEX Corporation
IRIX
|
$ 0.63 | 0.16 % | $ 10.7 M | USA |
 |
IRadimed Corporation
IRMD
|
$ 85.76 | 0.66 % | $ 1.09 B | USA |
 |
Neovasc
NVCN
|
- | - | $ 111 M |  Canada |
 |
AxoGen
AXGN
|
$ 43.39 | 0.16 % | $ 2 B | USA |
 |
Align Technology
ALGN
|
$ 146.78 | 0.79 % | $ 10.6 B | USA |
|
LENSAR
LNSR
|
$ 6.92 | 0.28 % | $ 82.7 M | USA |
 |
Sientra
SIEN
|
- | -16.59 % | $ 10.3 M | USA |
 |
Silk Road Medical, Inc
SILK
|
- | - | $ 1.07 B | USA |
 |
Medtronic PLC
MDT
|
$ 88.64 | 0.98 % | $ 114 B | USA |
 |
MiMedx Group
MDXG
|
$ 4.67 | 0.1 % | $ 690 M | USA |
 |
Surgalign Holdings
SRGA
|
- | -32.98 % | $ 1.68 M | USA |
 |
ShockWave Medical
SWAV
|
- | - | $ 12.3 B | USA |
 |
Myomo
MYO
|
$ 1.61 | 0.6 % | $ 67.4 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
$ 0.64 | 0.02 % | $ 41.5 M | Israel |
 |
InspireMD
NSPR
|
$ 0.7 | 0.71 % | $ 45 M | Israel |
 |
Orthofix Medical
OFIX
|
$ 9.44 | 3.06 % | $ 374 M |  Curacao |
 |
Outset Medical
OM
|
$ 3.05 | 1.29 % | $ 46.4 K | USA |
 |
Insulet Corporation
PODD
|
$ 136.13 | 0.26 % | $ 9.58 B | USA |
 |
Quanterix Corporation
QTRX
|
$ 3.27 | 2.83 % | $ 139 M | USA |
 |
Titan Medical
TMDI
|
- | -26.32 % | $ 19.6 M | Canada |
 |
AVITA Medical
RCEL
|
$ 11.84 | 2.25 % | $ 330 M |  Australia |
 |
Natus Medical Incorporated
NTUS
|
- | 1.94 % | $ 1.05 B | USA |
 |
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | USA |
 |
Apyx Medical Corporation
APYX
|
$ 2.96 | 4.59 % | $ 122 M | USA |
 |
Sintx Technologies
SINT
|
$ 1.88 | 0.53 % | $ 5.21 M | USA |
 |
Smith & Nephew plc
SNN
|
$ 26.91 | 0.86 % | $ 23.3 B | Britain |
 |
Accuray Incorporated
ARAY
|
$ 0.22 | 1.84 % | $ 27 M | USA |
 |
Inari Medical
NARI
|
- | - | $ 4.23 B | USA |
 |
Sensus Healthcare
SRTS
|
$ 2.94 | 1.03 % | $ 48 M | USA |
 |
Bruker Corporation
BRKR
|
$ 64.18 | 0.28 % | $ 9.74 B | USA |
 |
Stryker Corporation
SYK
|
$ 272.36 | 0.97 % | $ 104 B | USA |